CytomX

CytomX Therapeutics is a clinical-stage biopharmaceutical company based in South San Francisco, committed to revolutionizing cancer treatment through its innovative Probody therapeutics. By focusing on developing therapies that harness the body's own mechanisms to target cancer more effectively and with reduced toxicity, CytomX aims to provide a new generation of life-changing treatment options for patients.

The company's robust clinical-stage pipeline reflects its dedication to transforming cancer care, driven by a passionate team that values diversity, equity, and inclusion. CytomX embraces a mission-driven culture, recognizing the importance of collaboration and innovation in the pursuit of advancing scientific discoveries for a diverse patient population.

Generated from the website